Additionally, T-MSCs promoted the proportion of CSCs, as observed in ovarian cancer cell, probably because of upregulation of bone morphogenetic proteins (BMPs), such as BMP2, BMP4, and BMP6 in ovarian cancer-derived MSCs (86). This evidence concerns the gene BMP6 and ovarian cancer.